Ireland
--:--IST
Latest
Airmid Éireann 1.6 Adds India and China Trials, Swiss Prices Irish Cancer Trial Enrolment at 2.9%, Under Half 6% Target FDA Accelerated Approval for J&J's Head and Neck Cancer Drug Korea Misses 2026 Biosimilar Approvals, Bets on Keytruda ArrayPatch Closes €3.2m Seed for GLP-1 Microneedle Patch Sun Pharma Told to Halt Eye-Care Production at Assam Plant Airmid Éireann 1.6 Adds India and China Trials, Swiss Prices Irish Cancer Trial Enrolment at 2.9%, Under Half 6% Target FDA Accelerated Approval for J&J's Head and Neck Cancer Drug Korea Misses 2026 Biosimilar Approvals, Bets on Keytruda ArrayPatch Closes €3.2m Seed for GLP-1 Microneedle Patch Sun Pharma Told to Halt Eye-Care Production at Assam Plant
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Clinical Trials in China

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 07 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 5576 Shanghai 3879 Guangzhou 3345 Hangzhou 1819 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University481 Fudan University478 Second Affiliated Hospital, Zhejiang University, School of Medicine401 Ruijin Hospital289 Peking Union Medical College Hospital279
Site location
Beijing5576 Shanghai3879 Guangzhou3345 Hangzhou1819 Wuhan1343
All 625 locations
Target enrolment
to

Trials in this register

19187 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Guangzhou Virotech Pharmaceutical Co., Ltd.
Phase 2/3
66
Guangzhou
2026-05-13
Active, closed
Harbin Medical University
Observational
1,000
Harbin
2026-05-13
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
22
Tianjin
2026-05-13
Recruiting
Ruijin Hospital
Phase 1
18
Shanghai
2026-05-13
Recruiting
Tang-Du Hospital
Phase 2
60
Xi'an
2026-05-13
Recruiting
RemeGen Co., Ltd.
Phase 2/3
80
Beijing, Chongqing, Fuzhou, Meizhou, Nanjing, Shijiazhuang, Zhengzhou, Wuhan
2026-05-12
Recruiting
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
100
Guangzhou
2026-05-12
Recruiting
Jiangsu vcare pharmaceutical technology co., LTD
Phase 3
360
Nanjing
2026-05-12
Recruiting
Jilin University
Not applicable
36
Changchun, Ch’ang-ch’un
2026-05-12
Recruiting
Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation
NCT07444372Obstructive Sleep Apnea, Sleep Disorder (Disorder), Atrial Fibrillation (AF), Sleep Disordered Breathing (SDB)
Beijing Anzhen Hospital
Not applicable
658
Beijing, Fuzhou, Zhangzhou, Nanning, Langfang, Shijiazhuang, Xingtai, Harbin
2026-05-12
Active, closed
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1
64
Changsha
2026-05-12
Recruiting
Dose-Effect Response in Acupuncture for Functional Constipation
NCT07506122Functional Constipation (FC)
Tongji Hospital
Not applicable
72
Wuhan
2026-05-11
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Guangzhou, Shijiazhuang, Harbin, Changsha, Baotou, Changzhou, Nanjing, Suzhou
2026-05-11
Recruiting
Vigonvita Life Sciences
Phase 1
12
Hefei
2026-05-11
Recruiting
Ningbo Newbay Technology Development Co., Ltd
Phase 2/3
255
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Guiyang, Shijiazhuang
2026-05-11
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Beijing, Lanzhou, Foshan, Guangzhou, Harbin, Changsha, Baotou, Nanjing
2026-05-11
Recruiting
West China Hospital
Phase 2
30
Chengdu
2026-05-11
By invitation
China Medical University Hospital
Not applicable
162
2026-05-11
Recruiting
Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer
NCT07529626Pancreatic Tumor, Benign, Pancreatic Cancer, Adult, Pancreatic Cancer Resectable
Shanghai Zhongshan Hospital
Observational
320
Changsha, Shanghai, Xi’an
2026-05-11
Recruiting
CGM for Insulin-Treated T2DM During Post-Discharge Transition
NCT07414277Type 2 Diabetes Mellitus (T2DM)
Shanghai 6th People's Hospital
Not applicable
160
Shanghai
2026-05-11
Active, closed
SPH-BIOCAD (HK) Limited
Phase 1
48
Shanghai
2026-05-11
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
5
Hangzhou
2026-05-11
Not yet open
Jian Zhu
Phase 1
6
Haidian
2026-05-11
Recruiting
Shanghai Huilun Pharmaceutical Co., Ltd.
Phase 2/3
330
Chengdu
2026-05-11
Recruiting
Qilu Pharmaceutical Co., Ltd.
Phase 1
100
Taiyuan
2026-05-11
Recruiting
Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:
NCT07608003Gliomas Harboring IDH1 and/or IDH2 Mutations, Glioma Glioblastoma Multiforme, Glioma of Brainstem, Glioma, Diffuse Midline, H3K27M-mutant
Xiangya Hospital of Central South University
Observational
500
Changsha
2026-05-10
Active, closed
Yongxu Jia
Phase 2
34
Zhengzhou
2026-05-10
Recruiting
Tongji Hospital
Phase 4
100
Wuhan
2026-05-10
Not yet open
Hunan Province Tumor Hospital
Phase 2
50
Changsha
2026-05-10
Recruiting
Fudan University
Phase 2
40
Shanghai
2026-05-10
Not yet open
RDN for Heart Failure
NCT07558902Heart Failure
Shanghai Golden Leaf MedTec Co. Ltd
Not applicable
20
Shanghai
2026-05-10
Not yet open
Safety and Efficacy of JMKX000189 for Chemotherapy-Induced Peripheral Neuropathy
NCT07601386CIPN - Chemotherapy-Induced Peripheral Neuropathy
Shanghai Jeyou Pharmaceutical Co., Ltd.
Phase 1
18
Shanghai
2026-05-10
Recruiting
Tianjin Medical University Cancer Institute and Hospital
Observational
50
Tianjin
2026-05-10
Recruiting
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1
16
Hefei
2026-05-10
Not yet open
Multicenter Clinical Study on Robotic-Assisted Surgical Management of Posterior Cruciate Ligament Tibial Avulsion Fractures
NCT07575256PCL - Posterior Cruciate Ligament Deficiency, Posterior Cruciate Ligament Tear, PCL - Posterior Cruciate Ligament Rupture
Beijing Tsinghua Chang Gung Hospital
Not applicable
22
Beijing
2026-05-10
Recruiting
Efficacy of Liposomal Bupivacaine for Transversus Abdominis Plane Block
NCT07577934Postoperative Pain, Liposomal Bupivacaine
Tianjin First Central Hospital
Not applicable
86
Tianjin
2026-05-10
Recruiting
West China Hospital
Phase 1
9
Chengdu
2026-05-10
Not yet open
Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease
NCT07605624Aortic Stenosis, Aortic Regurgitation, Mitral Regurgitation, Tricuspid Regurgitation
Beijing Anzhen Hospital
Observational
5,500
Beijing
2026-05-10
Active, closed
Nanfang Hospital, Southern Medical University
Observational
80
Guangzhou
2026-05-10
Recruiting
Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases
NCT07558850Rheumatoid Arthritis, Dermatomyositis, Systemic Lupus Erythematosus, Systemic Sclerosis
The First Affiliated Hospital with Nanjing Medical University
Not applicable
72
Nanjing
2026-05-10
Recruiting
tDCS for Reducing the Incidence of OEI After Cesarean Section
NCT07569783Itching Symptoms, Itching Caused by Epidural Use of Opioids
Affiliated Hospital of Nantong University
Not applicable
104
Nantong
2026-05-10
Recruiting
Shanghai Huilun Pharmaceutical Co., Ltd.
Phase 2/3
330
Changsha
2026-05-09
Recruiting
Qilu Hospital of Shandong University
Not applicable
86
Jinan
2026-05-09
Recruiting
Fujian Cancer Hospital
Phase 2
35
Fuzhou
2026-05-09
Recruiting
Sinocelltech Ltd.
Phase 2/3
410
Guangzhou
2026-05-09
Recruiting
Liping Dou
Early Phase 1
18
Beijing
2026-05-09
Recruiting
DLL3-Targeted PET/CT in Small Cell Lung Cancer
NCT07677787PET/CT, Small Cell Lung Cancer ( SCLC ), DLL3-targeted PET/CT, Delta-like Protein 3
The First Affiliated Hospital of Xiamen University
Not applicable
20
Xiamen
2026-05-09
Recruiting
Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma
NCT07567742Oral Mucositis (Ulcerative) Due to Radiation, Nasopharyngeal Carcinoma (NPC)
DrugTaurine
Sun Yat-sen University
Phase 2
130
Guangzhou
2026-05-08
Not yet open
Sun Yat-sen University
Phase 3
442
Guangzhou
2026-05-08
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
24
Nanjing
2026-05-08
Recruiting
Safety and Efficacy of S103 Cells in Progressive/Refractory Multiple Sclerosis
NCT07587125Multiple Sclerosis (MS) Primary Progressive, Multiple Sclerosis, Multiple Sclerosis (MS) Secondary Progressive, Refractory Multiple Sclerosis
Xijing Hospital
Phase 1
9
Xi'an
2026-05-08
Recruiting
Institute of Hematology & Blood Diseases Hospital, China
Not applicable
27
Tianjin
2026-05-08
Active, closed
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
30
Beijing
2026-05-08
Recruiting
A Clinical Study of Cizutamig in Thyroid Eye Disease
NCT07597200Thyroid Eye Disease, TED
Candid Therapeutics
Phase 1
38
Hefei, Beijing, Fuzhou, Foshan, Guangzhou, Changsha, Wuhan, Nanchang
2026-05-08
Not yet open
AI-Assisted Optimization of Online Adaptive Radiotherapy for Gastric Lymphoma
NCT07609355Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)
Sun Yat-sen University
Not applicable
25
Guangzhou
2026-05-08
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
144
Chongqing
2026-05-08
Recruiting
General Hospital of Ningxia Medical University
Not applicable
1,617
Yinchuan
2026-05-08
Recruiting
CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
NCT07586267Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), Multi-Drug Resistant Nephrotic Syndrome, IgA Nephropathy (IgAN)
The Children's Hospital of Zhejiang University School of Medicine
Early Phase 1
15
Hangzhou
2026-05-08
Active, closed
Chengdu University of Traditional Chinese Medicine
Observational
300
Chengdu
2026-05-08
Recruiting
Beijing Friendship Hospital
Observational
5,000
Beijing
2026-05-08
Recruiting
Shanghai Shengdi Pharmaceutical Co., Ltd
Phase 3
874
Beijing
2026-05-07
Recruiting
Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML
NCT07617285AML, Refractory/Relapse Acute Myeloid Leukemia
Peking University People's Hospital
Phase 1
27
Beijing
2026-05-07
Recruiting
Guangzhou Virotech Pharmaceutical Co., Ltd.
Phase 2
10
Guangzhou
2026-05-07
Active, closed
Radar Sleep Monitoring in Type 1 Narcolepsy: Feasibility
NCT07654803Narcolepsy Type 1 (NT 1), Hypersomnolence Disorder
Xijing Hospital
Observational
1
Xi'an
2026-05-07
By invitation
Left Atrial Appendage Closure With Versus Without Pulsed Field Ablation in Atrial Fibrillation Patients With Mild Symptoms and High Stroke Risk
NCT07453940ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION, PFA Ablation and LAAC Procedures
Sir Run Run Shaw Hospital
Not applicable
50
Hangzhou
2026-05-07
Recruiting
VABu Conditioning in Elderly AML HSCT
NCT07583888Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Acute Myeloid Leukemia (AML)
The First Affiliated Hospital of Soochow University
Phase 2/3
20
Suzhou
2026-05-07
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
264
Fuzhou, Hangzhou, Huzhou, Jinhua, Ningbo, Wenzhou
2026-05-07
Recruiting
Tongji Hospital
Phase 2
60
Wuhan
2026-05-07
Recruiting
Mirati Therapeutics Inc.
Phase 2
170
Beijing, Xiamen, Zhengzhou, Changsha, Nanjing, Nanchang, Shenyang, Jinan
2026-05-06
Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Early Phase 1
12
Wuhan
2026-05-06
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
45
Hangzhou
2026-05-06
Not yet open
Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain
NCT07593365Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Breast Cancer, Pain Alleviation
Peking University People's Hospital
Not applicable
216
Beijing
2026-05-06
Not yet open
Ruijin Hospital
Phase 2
178
Shanghai
2026-05-06
Recruiting
General Hospital of Shenyang Military Region
Phase 2
122
Shenyang
2026-05-06
Recruiting
SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracranial Hemorrhage (SAFER-AF)
NCT07316270AF - Atrial Fibrillation, Intracranial Hemorrhage, Spontaneous
Beijing Anzhen Hospital
Not applicable
646
Hefei, Beijing, Xiamen, Harbin, Changchun, Xi'an
2026-05-06
Recruiting
Prospective, Multicenter, Randomized Controlled Phase III Trial of Biological Mesh for Alimentary Tract Reconstruction in Digestive Surgery
NCT07921732Digestive System Surgical Procedures, Anastomosis, Surgical, Postoperative Hemorrhage, Anastomotic Leaks
Nanfang Hospital, Southern Medical University
Not applicable
144
Guangzhou
2026-05-06
Not yet open
Xuanwu Hospital, Beijing
Not applicable
60
Beijing
2026-05-06
Recruiting
Fudan University
Observational
5,000
Shanghai
2026-05-06
By invitation
Zhujiang Hospital
Phase 1/2
44
Guanzhou
2026-05-06
Recruiting
Eli Lilly and Company
Phase 2
531
Binzhou, Chengdu, Guangzhou, Hangzhou, Hengyang, Huizhou, Huzhou, Meihekou
2026-05-06
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
1,020
Beijing, Guangzhou, Meizhou, Nanning, Hong Kong, Wuhan, Nanjing, Nanchang
2026-05-06
Recruiting
Hoffmann-La Roche
Phase 3
8
Guangzhou, Shanghai
2026-05-06
Recruiting
West China Hospital
Phase 1
9
Chengdu
2026-05-06
Recruiting
Fudan University
Phase 3
280
Shanghai
2026-05-06
Not yet open
MindRank AI Ltd
Phase 1
28
Changchun
2026-05-06
Recruiting
Jinling Hospital, China
Phase 2
75
Nanjing
2026-05-06
Recruiting
Jing-yuan Fang, MD, Ph. D
Not applicable
20
Shanghai
2026-05-06
Not yet open
Sun Yat-sen University
Phase 2
47
Guangzhou
2026-05-06
Not yet open
Henan Cancer Hospital
Phase 2
50
Zhengzhou
2026-05-05
Recruiting
Novo Nordisk A/S
Phase 3
300
Beijing, Guangzhou, Shenzhen, Luoyang, Nanjing, Tianjin
2026-05-05
Recruiting
Tang-Du Hospital
Phase 2
90
Xi'an
2026-05-05
Not yet open
Tianjin Medical University General Hospital
Not applicable
160
Tianjin
2026-05-05
Recruiting
Shandong Suncadia Medicine Co., Ltd.
Phase 3
912
Beijing
2026-05-05
Recruiting
Novo Nordisk A/S
Phase 3
300
Beijing, Nanjing, Suzhou, Zhenjiang, Huzhou
2026-05-05
Recruiting
Jinsong Hou
Not applicable
524
Guangzhou
2026-05-04
Recruiting
Eli Lilly and Company
Phase 2
60
Changsha, Changzhou, Guangzhou, Hangzhou, Huizhou, Suzhou, Wenzhou, Xiamen
2026-05-04
Recruiting
Eli Lilly and Company
Phase 2
60
Changsha, Changzhou, Guangzhou, Hangzhou, Huizhou, Suzhou, Wenzhou, Xiamen
2026-05-04
Recruiting
Gan Lijun
Not applicable
2,170
Beijing, Haikou, Harbin, Nanchang, Heze, Jinan, Jining, Liaocheng
2026-05-04
Recruiting
Impact of Hyperemic State on Angio-IMR Performance
NCT07613996Coronary Artery Disease, Microvascular Coronary Artery Disease
Shanghai Zhongshan Hospital
Observational
192
Shanghai, Guangzhou
2026-05-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
876
2026-05-04
Recruiting
AstraZeneca
Phase 3
670
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Jinan, Nanjing
2026-05-04
Active, closed
Xijing Hospital
Not applicable
240
Xi'an
2026-05-03
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
NCT07519772Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
DrugMK-1045
Merck Sharp & Dohme LLC
Phase 1/2
280
Beijing, Fuzhou, Guangzhou, Zhengzhou, Shanghai
2026-05-03
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
300
Beijing
2026-05-02
Not yet open
rhBNP for Prevention of Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI)
NCT07617675AKI - Acute Kidney Injury, Cardiac Surgical Procedures, Cardiopulmonary Bypass
China National Center for Cardiovascular Diseases
Phase 4
694
Beijing
2026-05-01
Not yet open
Eye & ENT Hospital of Fudan University
Not applicable
256
Shanghai
2026-05-01
Recruiting
GPC3-Targeted PET/CT in Hepatocellular Carcinoma
NCT07677774Hepatocellular Carcinoma (HCC), Glypican-3, GPC3-targeted PET/CT
The First Affiliated Hospital of Xiamen University
Not applicable
40
Xiamen
2026-05-01
Not yet open
Beijing Obstetrics and Gynecology Hospital
Not applicable
200
Beijing
2026-05-01
Recruiting
Fudan University
Phase 3
759
Shanghai
2026-05-01
Recruiting
SNRK & Vascular Endothelial Aging
NCT07591337Vascular Aging
Tianjin Medical University
Observational
180
Tianjin
2026-05-01
Not yet open
X-ray Assisted Diagnostic System
NCT07497243Chest X-ray for Clinical Evaluation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
16,000
Wuhan, Zhengzhou
2026-05-01
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
204
Beijing
2026-05-01
Not yet open
Fujian Medical University
Phase 1
6
Fuzhou
2026-05-01
Not yet open
18F-FAPI PET/CT and MRI in Gastric Cancer
NCT07510867Gastric Cancer
First Affiliated Hospital of Zhejiang University
Observational
230
Hangzhou
2026-05-01
Recruiting
China-Japan Friendship Hospital
Not applicable
200
Beijing
2026-05-01
By invitation
Chinese PLA General Hospital
Early Phase 1
60
Beijing
2026-05-01
Active, closed
The First Hospital of Jilin University
Phase 4
40
Changchun
2026-05-01
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
174
Hangzhou
2026-05-01
Not yet open
Beijing Tiantan Hospital
Not applicable
40
Beijing
2026-05-01
By invitation
Acute Kidney Injury in Critically Ill Patients
NCT07653321Acute Kidney Injury
Beijing Chao Yang Hospital
Observational
23,600
Beijing
2026-05-01
Recruiting
First Hospital of China Medical University
Observational
30
Shenyang
2026-05-01
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
118
Hangzhou, Fuzhou, Huzhou, Jinhua, Ningbo, Wenzhou
2026-05-01
Recruiting
Yung NA
Phase 2
68
Shanghai
2026-05-01
Recruiting
Evaluating Midline Catheters in Clinical Practice
NCT07677696Safety and Effectiveness of Midline Catheters, Vascular Access Devices
Shandong Branden Med.Device Co.,Ltd
Observational
10,000
Zibo
2026-05-01
Not yet open
SmartNuclide Biopharma
Early Phase 1
20
Tianjin
2026-05-01
Not yet open
An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models
NCT07555756Kidney Calculi, Prostatic Hyperplasia, Urinary Bladder Neoplasms
First Affiliated Hospital of Guangxi Medical University
Not applicable
1,080
Nanning
2026-05-01
Recruiting
First Hospital of China Medical University
Not applicable
210
Shenyang
2026-05-01
Not yet open
The First Affiliated Hospital with Nanjing Medical University
Observational
201
Nanjing
2026-05-01
Not yet open
The Experience of Short Video Addiction Among College Students
NCT07574021Behavior, Addictive, College Student
Sun Yat-sen University
Observational
30
Guangzhou
2026-05-01
Recruiting
The First Affiliated Hospital of Soochow University
Observational
100
Suzhou
2026-05-01
Not yet open
Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma
NCT07609446Indolent Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Mantle Cell Lymphoma
DrugsPomalidomide·Prednisone
The First Affiliated Hospital of Soochow University
Observational
30
Suzhou
2026-05-01
Not yet open
Neoadjuvant Radio-immunotherapy Versus Immunotherapy Alone for Locally Advanced HNSCC
NCT07554768Head and Neck Squamous Cell Carcinoma, Locally Advanced Head and Neck Squamous Cell Carcinoma
DrugAdebrelimab
Chen Chunyan
Phase 2
36
Guangzhou
2026-05-01
Not yet open
Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis
NCT07539779Luspatercept, Poor Erythroid Engraftment, Hematological Malignancies, Myelofibrosis (MF)
DrugLuspatercept
Nanfang Hospital, Southern Medical University
Phase 2/3
196
Guangzhou
2026-05-01
Not yet open
Phosphate-Containing Replacement Fluid for Patients Undergoing CRRT
NCT07550894Acute Kidney Injury, Sepsis, Critically Ill Patients Requiring Continuous Renal Replacement Therapy
Sun Yat-sen University
Phase 3
220
Chongqing, Guangzhou, Nanning, Luoyang, Zhengzhou, Wuhan, Nanjing, Xi'an
2026-05-01
Not yet open
Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases
NCT07343479NSCLC (Advanced Non-small Cell Lung Cancer), EGFR Gene Mutations, Brain Metastasis
DrugsEgfr-Tki·Sacituzumab tirumotecan
Zhejiang Cancer Hospital
Phase 2
45
Hangzhou
2026-05-01
Not yet open
First Affiliated Hospital of Zhejiang University
Phase 1/2
20
Hangzhou
2026-05-01
Not yet open
Longbio Pharma (Suzhou) Co., Ltd.
Phase 2
100
Beijing
2026-05-01
Active, closed
Guangxi Medical University
Observational
500
Nan'ning
2026-05-01
By invitation
Precision Antithrombotic Therapy
NCT07654634Non-valvular Atrial Fibrillation (NVAF), Venous Thromboembolism (VTE), MI(Myocardial Infarction), Ischemic Stroke
The Third Xiangya Hospital of Central South University
Observational
5,000
Changsha
2026-05-01
Not yet open
West China Hospital
Phase 3
412
Chengdu
2026-05-01
Not yet open
Capital University of Physical Education and Sports, China
Not applicable
60
Beijing
2026-05-01
Not yet open
Ningbo Medical Center Lihuili Hospital
Not applicable
204
Ningbo
2026-05-01
Not yet open
Areola Preservation in NSM With Nipple Involvement
NCT07544134Breast Cancer, Ductal Carcinoma In Situ, DCIS, Invasive Breast Carcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
40
Hangzhou
2026-05-01
Not yet open
China-Japan Union Hospital
Not applicable
220
Changchun
2026-05-01
Recruiting
Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure
NCT07528274NSCLC (Non-small Cell Lung Cancer), NSCLC (Advanced Non-small Cell Lung Cancer)
DrugsTislelizumab·Docetaxel
Tianjin Medical University Cancer Institute and Hospital
Phase 2
20
Tianjin
2026-05-01
Recruiting
Eye & ENT Hospital of Fudan University
Observational
200
Shanghai
2026-05-01
Recruiting
Beijing Tongren Hospital
Phase 2
40
Beijing
2026-05-01
Not yet open
The Affiliated Hospital of Qingdao University
Phase 4
20
Qingdao, Weihai, Yantai, Zibo
2026-05-01
Not yet open
Chinese PLA General Hospital
Phase 2
60
Beijing
2026-05-01
Recruiting
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
66
Shanghai
2026-05-01
Not yet open
Ming Yang
Phase 1
24
Beijing
2026-05-01
Not yet open
Peking Union Medical College Hospital
Phase 1
18
Beijing
2026-05-01
Not yet open
Denosumab Strategy for Liver Cancer With Bone Metastases
NCT07537972Hepatocellular Carcinoma (HCC), Bone Metastases
DrugsDenosumab·Sintilimab
Tongji Hospital
Phase 2
50
Wuhan
2026-05-01
Recruiting
Ruijin Hospital
Phase 2
205
Shanghai
2026-05-01
Not yet open
Fudan University
Phase 2
300
Shanghai
2026-05-01
Recruiting
Peking University First Hospital
Phase 3
192
Beijing
2026-05-01
Not yet open
The First Affiliated Hospital with Nanjing Medical University
Phase 1
12
Nanjing
2026-05-01
Not yet open
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Observational
132
Yiwu
2026-05-01
Not yet open
Chengdu Jinjiang Maternity and Child Health Hospital
Not applicable
270
Chengdu
2026-05-01
Recruiting
MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib
NCT07463651Acute Myeloid Leukemia (AML), FLT3-ITD Mutation, Allogeneic Hematopoietic Cell Transplantation (HCT), Maintenance Therapy
DrugsGilteritinib·Sorafenib
The First Affiliated Hospital of Soochow University
Phase 3
594
Suzhou, Shanghai
2026-05-01
Recruiting
Anti-CD25 Monoclonal Antibody for Prevention of Acute GVHD After Haploidentical HSCT
NCT07689630Graft Versus Host Disease, Hematologic Neoplasms
DrugMethotrexate
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3
186
Wuhan
2026-05-01
Recruiting
Personalized Neoantigen-pulsed Autologous Dendritic Cell Injections for Malignant Solid Tumors
NCT07752953Advanced Solid Tumor, Cancer, Malignant Solid Tumor
ZSky Biotech Inc
Not applicable
100
Qinhuangdao
2026-05-01
Recruiting
Tianjin Medical University Cancer Institute and Hospital
Phase 2
130
Tianjin
2026-05-01
Recruiting
Effect of Modified Arm Positioning on Shoulder Pain After Thoracoscopic Lobectomy
NCT07746323Ipsilateral Shoulder Pain, Lung Neoplasms
Chengdu Jinjiang Maternity and Child Health Hospital
Not applicable
270
Chengdu
2026-05-01
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
651
Beijing
2026-05-01
Not yet open
Xuanwu Hospital, Beijing
Not applicable
50
Beijing
2026-05-01
Not yet open
West China Hospital
Early Phase 1
10
Chengdu
2026-05-01
Not yet open
Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression
NCT07001995Small Cell Lung Cancer, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer NSCLC
DrugsEtoposide and carboplatin·Limertinib
Hunan Province Tumor Hospital
Phase 2
30
Changsha
2026-05-01
Recruiting
Peking University People's Hospital
Observational
60
Beijing
2026-05-01
Recruiting
Minimum Effective Dose of Ropivacaine for Ultrasound-guided Interscalene Block
NCT07326943Hand and Forearm Trauma, Hand and Forearm Diseases
Huazhong University of Science and Technology
Not applicable
56
Taiyuan
2026-05-01
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Phase 3
290
Shanghai
2026-05-01
Not yet open
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
2,000
Wuhan
2026-05-01
Not yet open
Huan Ye
Phase 1
9
Beijing
2026-05-01
Not yet open
UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma
NCT07500805CD70-positive Advanced Renal Clear Cell Carcinoma
UTC Therapeutics Inc.
Phase 1
21
Zhengzhou
2026-05-01
Not yet open
Effect of LSD on Lipid Profiles in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)
NCT07588334Cirrhosis, Liver, Splenectomy; Status, Portal Hypertension, Lipid Profiles
Northern Jiangsu People's Hospital
Observational
30
Yangzhou
2026-05-01
Not yet open
Kousai Bio Co., Ltd.
Phase 1
55
Wuhan, Shanghai
2026-05-01
Recruiting
The First Affiliated Hospital of Bengbu Medical University
Phase 2
38
Bengbu
2026-05-01
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
280
Hangzhou
2026-05-01
Not yet open
The Second Affiliated Hospital of Fujian Medical University
Phase 1
6
Quanzhou
2026-05-01
Not yet open
SCRT Based iTNT vs. LCRT Based TNT for MSS Locally Advanced Rectal Cancer
NCT07551479Locally Advanced Rectal Cancer (LARC), MSS (Microsatellite Stable)
DrugsCapecitabine·Oxaliplatin
Fudan University
Phase 3
612
Shanghai
2026-05-01
Recruiting
Prospective Multicenter Screening for Thoracic Disease Via Radiography
NCT07585214Pulmonary Diseases, Respiratory Disease, Esophageal Diseases
Chinese Academy of Sciences
Observational
300,000
Dazhou
2026-05-01
Not yet open
Effect of Laparoscopic Splenectomy on Renal Function in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)
NCT07585773Cirrhosis, Splenectomy; Status, Hypersplenism, Kidney Function Issue
Northern Jiangsu People's Hospital
Observational
30
Yangzhou
2026-05-01
Not yet open
Effect of taVNS on Perioperative Anxiety in Major Abdominal Surgery
NCT07495163Perioperative Anxiety, Major Abdominal Surgery
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
282
Huzhou, Jiaxing, Meicheng, Hangzhou
2026-05-01
Not yet open
Shanghai Chest Hospital
Not applicable
76
Shanghai
2026-05-01
Not yet open
Sirolimus-Coated vs Paclitaxel-Coated DCBs in ACS Treatment
NCT07514988Acute Coronary Syndromes (ACS)
China National Center for Cardiovascular Diseases
Not applicable
60
Beijing
2026-05-01
Not yet open
Chongqing University Cancer Hospital
Phase 2
20
Chongqing
2026-05-01
Active, closed
Wenjin Yin
Observational
2,946
Shanghai
2026-05-01
Not yet open
Beijing Tongren Hospital
Not applicable
120
Beijing
2026-05-01
By invitation
Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients
NCT07370441End-stage Renal Disease (ESRD), Peritoneal Dialysis (PD), Nutritional Status, Renal Replacement Therapy
DrugAmino acid (15) peritoneal dialysis
Shanghai 10th People's Hospital
Phase 4
50
Shanghai
2026-05-01
Not yet open
Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy
NCT07535138Membranous Nephropathy, Lupus Nephritis (LN), IgA Nephropathy (IgAN)
Air Force Military Medical University, China
Early Phase 1
15
Xi'an
2026-05-01
Not yet open
Clinical Study on the Preservation of Ovarian Function Following Hematopoietic Stem Cell Transplantation in Patients With Malignant Hematologic Diseases Using Goserelin
NCT07552480Allogeneic Haematopoietic Stem Cell Transplantation, Malignant Hematologic Disease, Ovarian Insufficiency
DrugGoserelin
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
64
Zhengzhou, Wuhan, Kunming, Hangzhou
2026-05-01
Not yet open
Effect of Laparoscopic Splenectomy on Lipid Profiles in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)
NCT07588373Cirrhosis, Splenectomy; Status, Hypersplenism, Lipid Profiles
Northern Jiangsu People's Hospital
Observational
30
Yangzhou
2026-05-01
Active, closed
Wenjin Yin
Observational
188
Shanghai
2026-05-01
Recruiting
BCI With 40Hz Stimulation in Alzheimer's Disease
NCT07618481Alzheimer Dementia (AD)
Ruijin Hospital
Not applicable
90
Shanghai
2026-05-01
Recruiting
Anterior Segment Anatomy Assessed by Swept-Source OCT in Ocular Surgery Patients
NCT07903454Cataract, Primary Angle-Closure Glaucoma
Nanfang Hospital, Southern Medical University
Observational
500
Guangzhou
2026-05-01
Not yet open
Tislelizumab Plus Chemotherapy and BACE for Unresectable NSCLC
NCT07561983Unresectable Stage III Non-small Cell Lung Cancer, Tislelizumab, Chemotherapy, Chemoembolization, Therapeutic
DrugTislelizumab
Sichuan Cancer Hospital and Research Institute
Phase 2
39
Chengdu
2026-05-01
Not yet open
Chengdu Jinjiang Maternity and Child Health Hospital
Not applicable
446
Chengdu
2026-05-01
Recruiting
Comparison of Double-tract and Tubular Gastric Anastomosis in Proximal Gastric Cancer
NCT07635836Gastric Cancer (GC), Double-tract Reconstruction, Tubular Gastric Anastomosis
Qilu Hospital of Shandong University
Not applicable
52
Jinan
2026-05-01
Not yet open
The First Affiliated Hospital of Zhengzhou University
Phase 3
564
Zhengzhou
2026-05-01
Not yet open
LLM-Based Intelligent Health Management Assistant in Life-Cycle Health Management of Cardiac Surgery Patients
NCT07521488Coronary Artery Bypass Grafting, Heart Valve Disease, Aortic Aneurysm, Aortic Dissection
Beijing Anzhen Hospital
Not applicable
500
Beijing
2026-05-01
Not yet open
Ke Dong, MD
Not applicable
24
Guangzhou
2026-05-01
Recruiting
Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous Female Donors
NCT07570745Graft-Versus-Host Disease(GVHD), Bone Marrow Transplantation
DrugsPTCy·Ivarmacitinib
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
82
Shanghai
2026-05-01
Not yet open
Tongji Hospital
Not applicable
30
Wuhan
2026-05-01
Not yet open
A Phase II Study of Benmelstobart + Anlotinib + Chemotherapy as First-Line Treatment for LCNEC and EP-NEC
NCT07510594Large-Cell Neuroendocrine Carcinoma of the Lung, Extrapulmonary Neuroendocrine Carcinoma
DrugsBenmelstobart·Anlotinib·Etoposide
Tianjin Medical University Cancer Institute and Hospital
Phase 2
48
Tianjin
2026-05-01
Recruiting
Mindfulness With Dual-Task Training in Post-Stroke Mild Cognitive Impairment
NCT07603102Stroke, Mild Cognitive Impairment (MCI)
Nanjing Mingzhou Rehabilitation Hospital
Not applicable
60
Nanjing
2026-05-01
Recruiting
RenJi Hospital
Phase 2
55
Shanghai
2026-05-01
Not yet open
Clinical Study on the Preservation of Ovarian Function in Patients With Aplastic Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation Using Goserelin
NCT07552506Aplastic Anaemia (AA), Allogeneic Haematopoietic Stem Cell Transplantation, Ovarian Insufficiency
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
132
Zhengzhou, Wuhan, Kunming, Hangzhou
2026-05-01
Recruiting
Characterization of Multi-Omics Landscapes and AI Pathological Prediction Model for Long-Term Survival in NSCLC Immunotherapy
NCT07668037Non-Small Cell Carcinoma of Lung, Immunotherapy, Advanced Non-Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
600
Beijing
2026-05-01
Recruiting
Safety and Efficacy of a Novel Composite-Tip Guiding Catheter in Transcarotid Artery Stenting Via Transradial Access
NCT07377422Transradial Carotid Artery Stenting, Novel Composite-tip Guiding Catheter
Beijing Anzhen Hospital
Not applicable
204
Beijing
2026-05-01
Not yet open
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
64
Zhengzhou, Wuhan, Kunming, Hangzhou
2026-05-01
Not yet open
Zhonghao Fang
Observational
2,700
Guangzhou
2026-05-01
Not yet open
The First Affiliated Hospital of Soochow University
Phase 2
52
Suzhou
2026-05-01
Not yet open
Ke Dong, MD
Not applicable
24
Guangzhou
2026-05-01
Not yet open
Tiaoshen Anti-cancer Protocol and CBT for Insomnia and Survival in Ovarian Cancer
NCT07550205Ovarian Neoplasms Malignant, Sleep Initiation and Maintenance Disorders, Medicine, Chinese Traditional, Chinese Herbal Medicine
Shanghai Municipal Hospital of Traditional Chinese Medicine
Phase 2/3
360
Shanghai
2026-05-01
By invitation
Zhejiang Provincial People's Hospital
Phase 2
30
Hangzhou
2026-05-01
Not yet open
Beijing Chao Yang Hospital
Phase 4
210
Beijing
2026-05-01
Not yet open
A Study of Ta-NPs Plus Radiotherapy for Locally Recurrent Retroperitoneal Sarcoma
NCT07578506Locally Recurrent Retroperitoneal Soft Tissue Sarcoma
West China Hospital
Phase 1
9
Chengdu
2026-05-01
Not yet open
Tang-Du Hospital
Phase 1
30
Xi'an
2026-05-01
Not yet open
West China Hospital
Not applicable
1,508
Chengdu
2026-05-01
Not yet open
Shanghai Mental Health Center
Not applicable
120
Shanghai
2026-05-01
Not yet open
Ticagrelor-Based Dual Antiplatelet Therapy Duration in CABG
NCT06981390Coronary Artery Disease, Coronary Artery Bypass Grafting, Saphenous Vein, Dual Antiplatelet Therapy
DrugTicagrelor
Kexiang Liu, MD
Not applicable
300
Changchun
2026-05-01
Not yet open
Lina Zhang
Not applicable
200
Hangzhou
2026-05
Not yet open
Rimegepant Plus Glofitamab and CD19 CAR-T Therapy in R/R LBCL
NCT07613788Relapsed/Refractory Large B-cell Lymphoma (LBCL)
DrugsRimegepant·Glofitamab·Obinutuzumab·Fludarabine
Ruijin Hospital
Phase 2
100
Shanghai
2026-05
Not yet open
LDRT Sequential NIPS Immunochemotherapy for Peritoneal Metastasis of Gastric and Colorectal Cancer
NCT07453875Peritoneal Metastasis of Gastric and Colorectal Cancer, LDRT
DrugsFolfox·Tislelizumab
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 1
9
Chongqing
2026-05
Recruiting
xiaojing wang
Not applicable
80
Taiyuan
2026-05
Not yet open
Application of Electromagnetic Navigation System in Pulmonary Nodule Localization
NCT07595120Pulmonary Nodules, Early-Stage Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Not applicable
400
Shanghai
2026-05
Not yet open
Shandong Suncadia Medicine Co., Ltd.
Phase 1
6
Jinan
2026-05
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Early Phase 1
6
Zhejiang
2026-05
Not yet open
Sinovac Biotech Co., Ltd
Phase 3
6,000
Hefei, Fujian, Henan, Hubei, Sichuan
2026-05
Not yet open
Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer
NCT07538193Carcinoma, Non-Small-Cell Lung (NSCLC), Neoplasm Staging, Lymphatic Metastasis
DrugIparomlimab and Tuvonralimab
Tang-Du Hospital
Not applicable
28
Xi'an
2026-05
Not yet open
Capital Medical University
Not applicable
200
Beijing
2026-05
Not yet open
Efficacy and Safety of Immune Checkpoint Inhibitors for Refractory Opportunistic Infections in AIDS
NCT07579247HIV, AIDS, Immune Checkpoint Inhibitors, Refractory Opportunistic Infection
DrugSintilimab
Shanghai Public Health Clinical Center
Phase 1/2
50
Shanghai
2026-05
Not yet open
Maternal-Fetal Heart Sound/Electrocardiogram Monitoring and Cardiac Risk Early Warning
NCT07526662Pregnancy-Associated Heart Disease, Fetal Congenital Heart Disease, Autoimmune-Related Fetal Heart Block, Perinatal Adverse Events
Yihua He,MD
Observational
1,000
Beijing
2026-05
Not yet open
High-Altitude Polycythemia Study
NCT07600086High-altitude Polycythemia, HAPC
Tibet Autonomous Region People's Hospital
Not applicable
70
Xizang
2026-05
Not yet open
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 3
356
Shanghai
2026-05
Not yet open
Prospective International Multi-center Clinical Trial of PGT-A Upgrade
NCT07533630Infertility Assisted Reproductive Technology
Reproductive & Genetic Hospital of CITIC-Xiangya
Observational
1,700
Changsha, Nanjing, Kunming
2026-05
Not yet open
Sun Yat-sen University
Phase 2
42
Foshan, Guangzhou, Qingyuan, Shantou, Shenzhen, Zhanjiang, Ganzhou
2026-05
Not yet open
Hebei Medical University Fourth Hospital
Phase 2
100
Shijiazhuang
2026-05
Not yet open
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1
30
Wuhan
2026-05
Not yet open
A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors
NCT07014878Colorectal Cancer, Lung Cancer, Pancreatic Cancer
Beijing DCTY Biotech Co.,Ltd.
Phase 1
18
Shanghai
2026-05
Not yet open
China-Japan Friendship Hospital
Not applicable
108
Beijing
2026-05
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
166
Hangzhou
2026-05
Recruiting
Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer
NCT07614061Biliary Tract Neoplasms, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma, Extrahepatic, Cholangiocarcinoma, Perihilar
DrugCyclophosphamide and Fludarabine
Shanghai Zhongshan Hospital
Phase 1
18
Shanghai
2026-05
Not yet open
Shanghai Mental Health Center
Phase 1
9
Shanghai
2026-05
By invitation
Anemia on Sublingual Microcirculation in GDFT
NCT07583927Anemia in Patients Undergoing Gastric Cancer Surgery Under Goal-directed Fluid Therapy, Macro-microcirculation Uncoupling
Fudan University
Observational
54
Shanghai
2026-05
Not yet open
Xi Wu
Not applicable
99
Chengdu
2026-05
Not yet open
Sinocelltech Ltd.
Phase 2
90
Wuhan
2026-05
Not yet open
Goniotomy in Primary Congenital Glaucoma
NCT07550868Primary Congenital Glaucoma, Goniotomy
Sun Yat-sen University
Observational
120
Guangzhou
2026-05
Not yet open
Tingting Luo
Not applicable
108
Chengdu
2026-05
Not yet open
Yunnan Baiyao Group Co., Ltd.
Phase 1/2
146
Beijing
2026-05
Not yet open
Zhonghao Fang
Observational
300
Guangzhou
2026-05
Recruiting
Correlation Of EUS-SWQ And Liver Fibrosis Pathology In Chronic Liver Disease
NCT07588854Chronic Liver Disease (CLD), Liver Fibrosis
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
65
Shanghai
2026-05
Not yet open
Preoperative Decision-Making in Patients With Pulmonary Nodules Suspected of Lung Cancer
NCT07590596Pulmonary Nodule, Suspected Lung Cancer, Preoperative Decision-Making
Sichuan Cancer Hospital and Research Institute
Observational
200
Chengdu
2026-05
Not yet open
iRegene Therapeutics Co., Ltd.
Phase 1
10
Hefei
2026-05
Recruiting
AbbVie
Phase 2/3
900
2026-04-30
Recruiting
Beijing Suncadia Pharmaceuticals Co., Ltd
Phase 2/3
126
Nanjing
2026-04-30
Recruiting
IMP3-saRNA Vaccine in Advanced NSCLC
NCT07561723Non-Small Cell Lung Cancer
West China Hospital
Phase 1
9
Chengdu
2026-04-30
Not yet open
Kunming Pharmaceuticals, Inc.
Phase 2
100
Hefei, Beijing, Chongqing, Guangzhou, Changsha, Shenyang, Kunming, Hangzhou
2026-04-30
Recruiting
Eli Lilly and Company
Phase 3
140
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hefei
2026-04-30
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Beijing, Shanghai
2026-04-30
Active, closed
DiproBio (Shanghai) Co., Ltd.
Observational
106,667
Shanghai
2026-04-30
Recruiting
First Affiliated Hospital of Wenzhou Medical University
Phase 2
134
Wenzhou
2026-04-30
Not yet open
A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced NSCLC Receiving Amivantamab-Based Regimens
NCT07469488NSCLC (Advanced Non-small Cell Lung Cancer), VTE (Venous Thromboembolism), Rash Due to Epidermal Growth Factor Receptor Inhibitors, Infusion Reaction
Shanghai Pulmonary Hospital, Shanghai, China
Phase 4
122
Shanghai
2026-04-30
Recruiting
ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
Phase 1/2
120
Beijing, Jilin City, Fuzhou, Xiamen, Lanzhou, Guangzhou, Guiyang, Zhengzhou
2026-04-30
Not yet open
Shanghai Henlius Biotech
Phase 1
24
Hefei
2026-04-30
Not yet open
Noninvasive Implantation Potential vs Morphology-Based Selection in IVF Single Blastocyst Transfer
NCT07461077Advanced Age, Recurrent Pregnancy Loss(RPL), Infertility (IVF Patients), Sequence Analysis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
520
Guangzhou
2026-04-30
Not yet open
The First Hospital of Jilin University
Observational
1,424
Changchun
2026-04-30
Not yet open
Inhaled Nitric Oxide for Prevention of Postoperative AKI in High-Risk Cardiac Surgery Patients
NCT07544147Cardiac Surgery Associated - Acute Kidney Injury, Cardiac Surgery With Cardiopulmonary Bypass
DrugNitric Oxide
Shanghai Zhongshan Hospital
Not applicable
330
Shanghai
2026-04-30
Not yet open
Luye Pharma Group Ltd.
Phase 1
8
Wuxi
2026-04-30
Recruiting
LaNova Medicines Limited
Phase 3
400
Beijing
2026-04-30
Recruiting
TIS for NSSI in Adolescent Depression
NCT07554755Temporal Interference Stimulation, Non Suicidal Self Injury, Major Depressive Disorder
The Second Hospital of Anhui Medical University
Not applicable
60
Hefei
2026-04-30
Recruiting
Ou Bai, MD/PHD
Phase 2
50
Changchun
2026-04-30
Not yet open
A Phase I Clinical Study of AK150 in Advanced Malignant Solid Tumor
NCT07566247Advanced Malignant Solid Tumors
Akeso
Phase 1
96
Fuzhou, Dongguan, Wuhan
2026-04-30
Not yet open
Hangzhou Dinova EP Technology Co., Ltd
Not applicable
350
Kunming
2026-04-30
Not yet open
Huazhong University of Science and Technology
Phase 4
400
Wuhan
2026-04-30
Not yet open
Covered vs Bare Metal Stents for Atherosclerotic Renal Artery Stenosis
NCT07566065Atherosclerotic Renal Artery Stenosis, Hypertension, Renal Artery Stenosis
Chinese Academy of Medical Sciences, Fuwai Hospital
Not applicable
150
Guangzhou, Harbin, Zhengzhou, Nanjing, Nanchang, Dalian, Jinan, Qingdao
2026-04-30
Recruiting
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 2
200
Beijing
2026-04-30
Not yet open
Beijing GoBroad Hospital
Phase 2
23
Beijing
2026-04-30
Recruiting
Exosome Therapy for Male Androgenetic Alopecia
NCT07693244Androgenetic Alopecia (AGA)
Zhang Han
Phase 2
120
Beijing
2026-04-30
Recruiting
The Effect of Sequential Therapy on Alzheimer's Disease
NCT07768579Mild Cognitive Impairment Due to Alzheimer Disease, Alzheimer Disease
Dongzhimen Hospital, Beijing
Observational
600
Beijing
2026-04-30
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 2
450
Beijing
2026-04-30
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
10
Beijing
2026-04-30
Recruiting
Zhejiang University
Phase 2
40
Hangzhou
2026-04-30
Recruiting
GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL
NCT06875063Non-hodgkin Lymphoma, Refractory Lymphoma, Chimeric Antigen Receptor T-cell
The First Affiliated Hospital of Xiamen University
Phase 1
45
Xiamen
2026-04-30
Not yet open
xieqing
Observational
10,000
Shanghai
2026-04-30
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
140
Guangzhou, Kunming
2026-04-30
Not yet open
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
16
Hangzhou
2026-04-30
Recruiting
GuangZhou Cellgenes Biotechnology Co., Ltd.
Phase 1/2
30
Guangzhou
2026-04-30
Recruiting
Second Xiangya Hospital of Central South University
Phase 1
88
Changsha
2026-04-30
Not yet open
Tasly Pharmaceutical Group Co., Ltd
Phase 3
450
Beijing
2026-04-30
Not yet open
Shanghai Zhongshan Hospital
Phase 1
24
Shanghai
2026-04-30
Not yet open
Efficacy of Lecanemab at Different Therapeutic Doses for Alzheimer's Disease (AD) in Real-World Practice
NCT07505095Alzheimer Disease (AD), Alzheimer Dementia, MCI-AD, Early Stage Alzheimer's Disease
DrugLecanemab
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
140
Hangzhou
2026-04-30
Recruiting
Tislelizumab Plus Zeprumetostat for Relapsed or Refractory NK/T-Cell Lymphoma
NCT07502768Extranodal NK/T-cell Lymphoma, NK/T-cell Lymphoma, Relapsed or Refractory NK/T-Cell Lymphoma
DrugsZeprumetostat·Tislelizumab
Rong Tao
Phase 1/2
107
Shanghai
2026-04-30
Not yet open
Eighth Affiliated Hospital, Sun Yat-sen University
Not applicable
20
Shenzhen
2026-04-30
Recruiting
HELP Therapeutics Co., Ltd.
Phase 3
80
Tianjin
2026-04-30
Recruiting
Guangdong Association of Clinical Trials
Phase 2
61
Guangzhou
2026-04-30
Not yet open
Surgery Plus Systemic Therapy for Liver Cancer With Extrahepatic Metastases
NCT07537959Hepatocellular Carcinoma (HCC), Metastasis
Tongji Hospital
Not applicable
280
Wuhan
2026-04-30
Not yet open
Gan & Lee Pharmaceuticals.
Phase 1
65
Beijing
2026-04-30
Recruiting
Tongji University
Phase 2
150
Shanghai
2026-04-30
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Observational
200
Beijing
2026-04-30
Recruiting
A Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions
NCT07532538Hypopharyngeal Cancer, Laryngeal Cancer, Head and Neck Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
3,000
Nanjing
2026-04-30
Not yet open
Tasly Pharmaceutical Group Co., Ltd
Phase 2/3
180
Beijing
2026-04-30
Not yet open
Multi-Site Cortical Puncture for DOR
NCT07568639Diminished Ovarian Reserve (DOR)
First Affiliated Hospital of Guangxi Medical University
Not applicable
214
Xiamen, Guigang, Liuzhou, Nanning, Qinzhou
2026-04-30
Recruiting
The Second Hospital of Anhui Medical University
Not applicable
60
Hefei
2026-04-30
Not yet open
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
20
Jinan
2026-04-30
Recruiting
Becotatug Vedotin ± Anti-PD-1 in Pretreated Advanced ESCC
NCT07403136Esophageal Squamous Cell Carcinoma
Fudan University
Phase 2
104
Shanghai
2026-04-30
Not yet open
Dartsbio Pharmaceuticals Ltd.
Phase 1/2
58
Guangzhou
2026-04-30
Recruiting
A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma
NCT07548697B-cell Non Hodgkin Lymphoma (NHL), DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma (FL)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Early Phase 1
24
Wuhan
2026-04-30
Recruiting
Multitude Therapeutics Inc.
Phase 2
180
Fuzhou, Nanning, Guangzhou, Harbin, Luoyang, Wuhan, Changsha, Shengyang
2026-04-29
Recruiting
AstraZeneca
Observational
3,000
Beijing
2026-04-29
Recruiting
Peking Union Medical College Hospital
Phase 2
70
Beijing
2026-04-29
Active, closed
First Affiliated Hospital of Fujian Medical University
Phase 2
25
Fuzhou
2026-04-29
Recruiting
Eli Lilly and Company
Phase 2
342
Binzhou, Chengdu, Guangzhou, Hangzhou, Hengyang, Huizhou, Huzhou, Meihekou
2026-04-29
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
90
Jinan
2026-04-29
Active, closed
Taiwan Municipal An-Nan Hospital-China Medical University
Phase 2
44
2026-04-29
Recruiting
ChinaNorm
Not applicable
76
Shanghai
2026-04-28
Not yet open
Fujian Medical University Union Hospital
Observational
3,000
Fujian
2026-04-28
Recruiting
A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer
NCT07497386Unresectable Locally Recurrent Breast Cancer, Unresectable Locally Metastatic Breast Cancer
DrugsTrastuzumab Rezetecan·Trastuzumab deruxtecan
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
150
Beijing
2026-04-28
Recruiting
Shanghai StairMed Technology Co., Ltd.
Not applicable
34
Shanghai
2026-04-28
Not yet open
West China Hospital
Phase 1
9
Chengdu
2026-04-28
Recruiting
West China Hospital
Phase 1
9
Chengdu
2026-04-28
Recruiting
West China Hospital
Phase 1
6
Chengdu
2026-04-28
Not yet open
Second Affiliated Hospital of Nanchang University
Phase 2
25
Nanchang
2026-04-28
Recruiting
Biogen
Phase 3
30
Zhengzhou, Guangzhou, Shanghai
2026-04-28
Active, closed
Capital Medical University
Phase 1
92
Zhangzhou, Jiuquan, Yulin, Shangqiu, Xuzhou, Beijing, Zibo, Huzhou
2026-04-28
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
NCT07354074Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
DrugsAsciminib single agent·ABL001
Novartis Pharmaceuticals
Phase 2
50
Zhengzhou, Tianjin
2026-04-28
Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Early Phase 1
36
Wuhan
2026-04-28
Recruiting
Eye & ENT Hospital of Fudan University
Phase 2
40
Shanghai
2026-04-28
Not yet open
Shenyang Medical College
Not applicable
60
Shenyang
2026-04-28
Recruiting
Nanjing Medical University
Phase 2/3
96
Nanjing
2026-04-27
Recruiting
Bayer
Phase 2
250
Hefei, Beijing, Fuzhou, Lanzhou, Guangzhou, Shijiazhuang, Harbin, Zhengzhou
2026-04-27
Recruiting
Mesenchymal Stem Cells in the Treatment of Burn Wounds
NCT07580755Burn Injury, Burn Patients
The First Affiliated Hospital of Xinxiang Medical College
Not applicable
90
Xinxiang
2026-04-27
Recruiting
RemeGen Co., Ltd.
Phase 1/2
326
Hunan, Sichuan, Fujian, Guangdong, Guizhou, Heilongjiang, Changsha, Nanjing
2026-04-27
By invitation
Harbin Medical University
Not applicable
14,980
Daqing, Harbin, Hegang, Jiamusi, Mudanjiang, Qiqihar, Shuangyashan, Suihua
2026-04-27
Recruiting
Dragonboat Biopharmaceutical Company Limited
Phase 2
96
Shanghai
2026-04-27
Recruiting
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
NCT07557225Clear Cell Renal Cell Cancer (ccRCC), Urothelial Carcinoma (UC), Colorectal Cancer, Cervical Cancer
Peking University First Hospital
Not applicable
200
Beijing
2026-04-27
Recruiting
Hoffmann-La Roche
Phase 3
360
Beijing, Fuzhou, Guangzhou, Chengdu, Tianjin
2026-04-27
Recruiting
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2
105
Hefei, Beijing, Chongqing, Fuzhou, Dongguan, Guangzhou, Shijiazhuang, Zhengzhou
2026-04-27
Not yet open
Gan & Lee Pharmaceuticals.
Phase 3
140
Beijing
2026-04-27
Active, closed
Development and Validation of an AI Foundation Model for Frozen-Section Pathology
NCT07708207Cancer, Intraoperative Pathology, Artificial Intelligence (AI)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
33,000
Guangzhou
2026-04-27
Recruiting
First Affiliated Hospital of Zhejiang University
Not applicable
70
Hangzhou
2026-04-27
Recruiting
Sir Run Run Shaw Hospital
Not applicable
152
Hangzhou
2026-04-27
Recruiting
Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity
NCT07803809Overweight , Obesity, Type 2 Diabetes Mellitus (T2DM), MASH - Metabolic Dysfunction-Associated Steatohepatitis
Shanghai Minwei Biotechnology Co., Ltd
Phase 1
36
Kunming
2026-04-26
Recruiting
University of Electronic Science and Technology of China
Not applicable
80
Chengdu
2026-04-26
Not yet open
Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis（ECHO-TAVR）
NCT07317804Aortic Stenosis, TAVI, TAVI(Transcatheter Aortic Valve Implantation)
China National Center for Cardiovascular Diseases
Phase 4
212
Beijing
2026-04-26
Not yet open
Shanghai Mental Health Center
Not applicable
158
Shanghai
2026-04-25
Recruiting
Peking University First Hospital
Not applicable
70
Beijing
2026-04-25
Not yet open
Shanghai Henlius Biotech
Phase 2
180
Harbin
2026-04-25
Recruiting
Third Military Medical University
Not applicable
208
Xigazê
2026-04-25
Recruiting
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
80
Shanghai
2026-04-25
Recruiting
Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease
NCT07547930Thyroid Eye Disease, TED, Graves Ophthalmopathy, Graves Orbitopathy
DrugTofacitinib
The First Affiliated Hospital of Xiamen University
Phase 2
8
Xiamen
2026-04-24
Recruiting
A Study in Adults With Desmoid Tumors
NCT07541430Desmoid Tumor
DrugES014
Elpiscience (Suzhou) Biopharma, Ltd.
Phase 2
50
Beijing
2026-04-24
Recruiting
A Novel Two-Tooth Clip for ESD and EFTR of GIST
NCT07581977GIST - Gastrointestinal Stromal Tumor
Affiliated Hospital to Academy of Military Medical Sciences
Not applicable
60
Beijing
2026-04-24
Not yet open
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
40
Guangzhou
2026-04-24
Recruiting
AstraZeneca
Phase 3
230
Beijing, Bengbu, Cangzhou, Changsha, Chengdu, Chongqing, Foshan, Fuzhou
2026-04-24
Recruiting
Spatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer Cachexia
NCT07670286Pancreatic Cancer, Cachexia; Cancer; Sarcopenia
Peking Union Medical College Hospital
Observational
500
Beijing
2026-04-24
Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3
378
Wuhan
2026-04-24
Recruiting
Gang Hou
Phase 1/2
105
Beijing
2026-04-24
Recruiting
Ruijin Hospital
Phase 2
60
Shanghai
2026-04-24
Active, closed
Tianjin Medical University Cancer Institute and Hospital
Phase 2
107
Tianjin
2026-04-24
Recruiting
Sinomune Pharmaceutical Co., Ltd
Phase 1
48
Suzhou
2026-04-24
Active, closed
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
180
Qingdao
2026-04-24
Active, closed
Shandong Suncadia Medicine Co., Ltd.
Phase 2
61
Chongqing, Zhengzhou
2026-04-23
Recruiting
Merck Sharp & Dohme LLC
Phase 3
590
Beijing, Chongqing, Guangzhou, Zhuhai, Wuhan, Changsha, Nanjing, Nanchang
2026-04-23
Recruiting
Eli Radiopharma
Phase 1
18
Beijing
2026-04-23
Recruiting
Nanjing Chia-tai Tianqing Pharmaceutical
Phase 1
56
Beijing
2026-04-23
Recruiting
SKB103 for Injection in Advanced Solid Tumors
NCT07459998Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1/2
277
Harbin, Shanghai
2026-04-23
By invitation
Guangzhou University of Chinese Medicine
Not applicable
70
Guangzhou
2026-04-23
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3
336
Shanghai
2026-04-23
Recruiting
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
410
Beijing
2026-04-23
Recruiting
Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
NCT07303777Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management
Atom Therapeutics Co., Ltd
Phase 2
200
Beijing, Dalian, Guangzhou, Hangzhou, Jinan, Nanjing, Shanghai, Suzhou
2026-04-23
Not yet open
Prognostic Value of Metabolic Characteristics in High-Risk Populations for Acute Kidney Injury After Cardiac Surgery
NCT07521787Cardiac Surgery Associated - Acute Kidney Injury, Critical Illness
Shanghai Zhongshan Hospital
Observational
540
Shanghai
2026-04-23
Recruiting
International Peace Maternity and Child Health Hospital
Phase 2
29
Shanghai
2026-04-23
Recruiting
The General Hospital of Western Theater Command
Early Phase 1
20
Chengdu
2026-04-23
By invitation
Wearable-Based Study of Depression and Sleep in Older Adults
NCT07232472Elderly Depression, Sleep Disturbance
China Medical University Hospital
Not applicable
162
2026-04-23
Recruiting
West China Hospital
Phase 1
6
Chengdu
2026-04-23
Recruiting
Daoyin Technique for Improving Exercise Endurance in IPF
NCT07019714Idiopathic Pulmonary Fibrosis
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Not applicable
236
Beijing, Zhengzhou, Shenyang
2026-04-22
Recruiting
Jiangsu Taizhou People's Hospital
Not applicable
320
Taizhou
2026-04-22
Recruiting
Huahui Health
Phase 3
160
Changchun, Kashgar, Ürümqi
2026-04-22
Recruiting
Digital Technology for Active and Healthy Ageing in Taiwan
NCT07232667Healthy Aging, Digital Health Literacy
China Medical University Hospital
Observational
140
2026-04-22
Recruiting
BioNTech SE
Phase 3
736
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Hangzhou, Hefei, Nanchang
2026-04-22
Active, closed
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1
208
Wuhan
2026-04-22
Recruiting
General Hospital of Ningxia Medical University
Not applicable
960
Yinchuan
2026-04-22
Not yet open
Ongericimab Injection Reducing Recurrence of Ischemic Stroke
NCT07242599Ischemic Cerebral Infarction
Beijing Tiantan Hospital
Phase 3
4,810
Fuyang, Wuhu, Beijing, Chongqing, Ningde, Dingxi, Jiuquan, Lanzhou
2026-04-22
Recruiting
Ruijin Hospital
Not applicable
1,950
Shanghai
2026-04-22
Recruiting
Capital Medical University
Phase 3
348
Huaibei, Suzhou, Heyuan, Maoming, Qinhuangdao, Tangshan, Anyang, Hebi
2026-04-22
Not yet open
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
32
Qingdao
2026-04-22
By invitation
CHT105 for the Treatment of Refractory Lupus Nephritis
NCT07517536Systemic Lupus Erythematosus, Lupus Nephritis
DrugCHT105
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
14
Nanjing
2026-04-22
Active, closed
AstraZeneca
Not applicable
4,000
Beijing, Changlexi, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangdong Province
2026-04-21
Recruiting
Ke Dong, MD
Not applicable
60
Guangzhou
2026-04-21
Recruiting
Janssen Research & Development, LLC
Phase 3
530
Changzhou, Chongqing, Fuzhou, Guangzhou, Nanjing, Wuhan
2026-04-21
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
596
Guangzhou, Chengdu
2026-04-21
Recruiting
Ruijin Hospital
Phase 2
88
Shanghai
2026-04-21
Recruiting
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1
100
Shanghai
2026-04-21
Recruiting
Joint Biosciences Ltd.
Phase 1
18
Beijing
2026-04-21
Recruiting
Shenzhen University General Hospital
Phase 2
10
Shenzhen
2026-04-21
Recruiting
JS212 Plus JS111 in EGFR-Mutant Advanced NSCLC: A Phase II Study
NCT07518160Locally Advanced, Metastatic, or Recurrent Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations
DrugJS111
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
35
Shanghai
2026-04-21
Not yet open
Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis
NCT07545213Non-small Cell Lung Cancer, EGFR Mutant Advanced Non-small Cell Lung Cancer
DrugsAnlotinib·Sacituzumab tirumotecan
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase 2
27
Yiwu
2026-04-20
By invitation
Sun Yat-sen University
Phase 2
42
Foshan, Guangzhou, Shantou, Shenzhen, Zhanjiang
2026-04-20
Recruiting
Controlled Cold Exposure Combined With PD-1/PD-L1 Immunotherapy in Solid Tumors (NIVALIS)
NCT07538479Solid Tumors, Solid Malignancies, Cold Exposure, Immunotherapy
West China Hospital
Phase 1
24
Chengdu
2026-04-20
Not yet open
Beijing Chao Yang Hospital
Not applicable
70
Beijing
2026-04-20
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
44
Shanghai
2026-04-20
Recruiting
The First Affiliated Hospital of Xinxiang Medical College
Not applicable
30
Xinxiang
2026-04-20
Recruiting
LinGang Laboratory
Phase 1
100
Shanghai
2026-04-20
Not yet open
Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy
NCT07537777Hepatocellular Carcinoma (HCC), First-line Targeted Therapy Failure, Oligometastatic Hepatocellular Carcinoma, Benmelstobart
DrugsBenmelstobart·Anlotinib
Nanfang Hospital, Southern Medical University
Phase 2
29
Guangzhou
2026-04-20
Recruiting
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
NCT07459283Maligant Solid Tumor, Head & Neck Cancer, Thyroid Cancer, Lung Cancer - Non Small Cell Squamous
FindCure Biosciences (ZhongShan) Co., Ltd.
Early Phase 1
10
Wuxi
2026-04-20
Recruiting
The First Affiliated Hospital of Xinxiang Medical College
Not applicable
30
Xinxiang
2026-04-20
Recruiting
IBI343 in Combination Therapy for Advanced Malignant Solid Tumors
NCT07483554CLDN18.2 Positive, Gastric/Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal Adenocarcinoma
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
389
Hangzhou
2026-04-20
Recruiting
Qilu Pharmaceutical Co., Ltd.
Phase 3
466
Beijing
2026-04-20
Active, closed
Bisirna Therapeutics (Suzhou) Co., Ltd.
Phase 1
40
Beijing
2026-04-20
Recruiting
Screening for Biomarkers of Osteonecrosis of the Femoral Head
NCT07545616Osteonecrosis of the Femoral Head
The First Affiliated Hospital of Xinxiang Medical College
Observational
300
Xinxiang
2026-04-20
Not yet open
University of Southern Queensland
Not applicable
76
Zunyi
2026-04-20
Recruiting
Zhejiang Cancer Hospital
Phase 2
20
Hangzhou
2026-04-20
Recruiting
Zhongshan Ophthalmic Center, Sun Yat-sen University
Observational
300
Guangzhou
2026-04-20
Not yet open
A Multicenter Cohort Study of Duchenne and Becker Muscular Dystrophy in Western Chinese Children
NCT07511920Muscular Dystrophy, Becker, Muscular Dystrophy, Muscular Dystrophy (DMD), Muscular Dystrophy, Duchenne
West China Second University Hospital
Observational
500
Chengdu
2026-04-20
Not yet open
RemeGen Co., Ltd.
Phase 3
260
Beijing
2026-04-20
Not yet open
Beijing Tiantan Hospital
Observational
120
Beijing
2026-04-20
Not yet open
Chinese PLA General Hospital
Observational
180
Beijing
2026-04-20
Recruiting
Beijing Shijitan Hospital, Capital Medical University
Observational
129
Beijing, Harbin, Dalian, Weifang
2026-04-20
Recruiting
Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet
NCT06201013Urinary Bladder, Overactive, Overactive Bladder, Urinary Incontinence, Urge
DrugsSolifenacin Succinate·Cholecalciferol
Children's Hospital of Chongqing Medical University
Not applicable
180
Chongqing
2026-04-20
Recruiting
Guangzhou Women and Children's Medical Center
Observational
1,050
Guangxi, Xi’an
2026-04-20
Recruiting
CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment
NCT07366112Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer, Early-Stage Breast Cancer, HER2-negative Breast Cancer
Peking University People's Hospital
Phase 2
158
Beijing
2026-04-20
Recruiting
First Affiliated Hospital of Fujian Medical University
Not applicable
24
Fuzhou
2026-04-20
Recruiting
Sun Yat-sen University
Phase 3
556
Guangzhou
2026-04-20
Recruiting
Xijing Hospital of Digestive Diseases
Phase 4
226
Ankang, Hanzhong, Xi'an, Xianyang
2026-04-20
Not yet open
Peking Union Medical College Hospital
Early Phase 1
408
Beijing
2026-04-20
Recruiting
Boehringer Ingelheim
Phase 2
405
Beijing, Changchun, Changsha, Guangzhou, Linfen, Nanjing, Ningbo, Shanghai
2026-04-20
Not yet open
The Hong Kong Polytechnic University
Not applicable
60
Qingyuan
2026-04-20
Recruiting
Screening for Biomarkers of Osteoarthritis
NCT07544823Osteoarthritis (OA)
The First Affiliated Hospital of Xinxiang Medical College
Observational
300
Xinxiang
2026-04-20
Not yet open
GS1-144 in Participants With Hepatic Impairment and Healthy Female
NCT07491289Hepatic Impairment and Healthy Female
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
24
Changchun
2026-04-20
Not yet open
Trans-round Window Membrane Intracochlear Steroid
NCT07540728Sudden Hearing Loss
Eye & ENT Hospital of Fudan University
Phase 2
108
Shanghai
2026-04-20
Not yet open
Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing
NCT07312370Early Gastric Cancer, Gastric Dysplasia, Gastric Neoplasms, Peptic Ulcer With Haemorrhage
DrugsSucralfate·Esomeprazole
LanZhou University
Phase 4
120
Lanzhou
2026-04-20
Recruiting
Transcutaneous Electrical Acupoint Stimulation at Jing-Well Points for Disorders of Consciousness
NCT07535593Disorders of Consciousness Due to Severe Brain Injury
Xijing Hospital
Phase 2/3
160
Xi'an
2026-04-20
Recruiting
Qilu Hospital of Shandong University
Observational
176
Jinan
2026-04-20
Not yet open
The Efficacy and Safety of Sonrotoclax, Zanubrutinib Combined With Obinutuzumab in MCL
NCT07548255Intermediate-to-High-Risk Mantle Cell Lymphoma, the Efficacy and Safety
DrugObinutuzumab
Ruijin Hospital
Phase 1
28
Shanghai
2026-04-20
Recruiting
Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07601737Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Head & Neck Cancer, Neoadjuvant Therapy
DrugsAlbumin-Bound Paclitaxel /nab-Paclitaxel·Nimotuzumab·Tislelizumab·Docetaxel
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
182
Shanghai
2026-04-20
Not yet open
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
40
Guangzhou
2026-04-20
Not yet open
Shenyang Medical College
Not applicable
214
Shenyang
2026-04-19
Recruiting
Shanghai Mental Health Center
Not applicable
84
Shanghai
2026-04-19
Recruiting
Shanghai Mental Health Center
Not applicable
84
Shanghai
2026-04-19
Not yet open
Second Xiangya Hospital of Central South University
Not applicable
472
Quanzhou, Guangzhou, Harbin, Luoyang, Wuhan, Changde, Changsha, Loudi
2026-04-18
Recruiting
Guangdong Provincial People's Hospital
Not applicable
140
Guangzhou
2026-04-18
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
160
Shanghai
2026-04-18
Recruiting
Ruijin Hospital
Phase 2
74
Shanghai
2026-04-17
Not yet open
Shanghai Mabgeek Biotech.Co.Ltd
Phase 3
180
Shenyang
2026-04-17
Recruiting
Beijing Friendship Hospital
Observational
5,000
Beijing
2026-04-17
Recruiting
Jiangsu Cancer Institute & Hospital
Phase 2
34
Nanjing
2026-04-17
Recruiting
Shanghai Henlius Biotech
Phase 1
138
Beijing, Shanghai
2026-04-17
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
90
Beijing
2026-04-17
Not yet open
Peking University Third Hospital
Not applicable
400
Beijing
2026-04-17
Recruiting
Fudan University
Phase 2
40
Shanghai
2026-04-17
Recruiting
Hangzhou Sumgen Biotech Co., Ltd.
Phase 1/2
40
Zhengzhou, Suzhou, Xi’an, Hangzhou
2026-04-16
Recruiting
Ipsen
Observational
20
Beijing, Chongqing, Hunan, Nanjing, Shanghai, Xiamen
2026-04-16
Recruiting
Zhejiang Cancer Hospital
Phase 2
60
Hangzhou
2026-04-16
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
150
Hong Kong
2026-04-16
Recruiting
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
665
Guangzhou
2026-04-16
Recruiting
Yonghong Li
Phase 2
109
Guangzhou, Meizhou
2026-04-16
By invitation
ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.
Phase 1
60
Beijin, Shijiazhuang
2026-04-16
Recruiting
Sun Yat-sen University
Phase 3
260
Guangzhou, Changsha, Fuzhou, Hangzhou, Nanning
2026-04-16
Not yet open
The Second Affiliated Hospital of Hainan Medical University
Phase 2/3
400
Haikou
2026-04-15
Not yet open
Chengdu Syncor Pharmaceutical Co., Ltd.
Phase 2
80
Tianjin
2026-04-15
Not yet open
Ruijin Hospital
Observational
64
Shanghai
2026-04-15
Recruiting
Peking Union Medical College Hospital
Phase 2
70
Beijing
2026-04-15
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
156
Tianjin
2026-04-15
Recruiting
Xuekui Liu
Phase 2
40
Guangzhou
2026-04-15
Recruiting
First Affiliated Hospital of Zhejiang University
Observational
200
Hangzhou
2026-04-15
Recruiting
Beijing 302 Hospital
Phase 2
48
Beijing
2026-04-15
Recruiting
Akeso
Phase 3
386
Guangzhou
2026-04-15
Recruiting
Picankibart in Palmoplantar Pustulosis
NCT07552454Palmoplantar Pustulosis
DrugPicankibart
Xijing Hospital
Not applicable
60
Xi'an
2026-04-15
Recruiting
Corticosteroids in Hyperinflammatory Phenotype of Critical Illness
NCT07511582Sepsis, Acute Respiratory Distress Syndrome
DrugMethylprednisolone
Bin Du
Phase 2
150
Beijing
2026-04-15
Recruiting
Xuanwu Hospital, Beijing
Not applicable
264
Beijing, Fuzhou, Shijiazhuang, Harbin, Nanyang, Zhengzhou, Baotou, Xi'an
2026-04-15
Not yet open
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
255
Shanghai
2026-04-15
Not yet open
Institute of Hematology & Blood Diseases Hospital, China
Early Phase 1
24
Tianjin
2026-04-15
Recruiting
Wang Xin
Phase 2
64
Chengdu
2026-04-15
Not yet open
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
170
Beijing
2026-04-15
Not yet open
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
27
Shenzhen, Zhengzhou, Nanchang, Jinan, Tianjin
2026-04-15
Recruiting
Pre-operative Risk Assessment Combined With Targeted Intervention in the Chinese Elderly With Spine Surgery II
NCT07396077Spine Degeneration, Lumbar Degenerative Disease, Frail Elderly, Enhanced Recovery After Surgery (ERAS) Protocol
Xuanwu Hospital, Beijing
Not applicable
248
Beijing
2026-04-15
Not yet open
yilong Wang
Not applicable
6
Beijing
2026-04-15
Active, closed
AI-Assisted Mindfulness Intervention in Emotional Distress
NCT07542561Subclinical Depression, Subclinical Anxious Adults, Subclinical Emotional Distress
Xinghua Liu
Not applicable
550
Beijing
2026-04-15
Not yet open
Using Real-Time Lung Visuals to Reduce Mental Strain and Improve Diagnosis Speed
NCT07511712Mechanical Ventilation, Clinical Competence, Education Curriculum, Self Concept
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
34
Hangzhou
2026-04-15
Not yet open
Shanghai 10th People's Hospital
Observational
88
Shanghai
2026-04-15
Recruiting
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 3
752
Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Wuwei
2026-04-15
Recruiting
Hoffmann-La Roche
Phase 3
100
Hangzhou, Shanghai
2026-04-15
Recruiting
Dizal Pharmaceuticals
Phase 1/2
220
Chongqing, Fuzhou, Nanning, Zhengzhou, Wuhan, Nanjing, Chengdu, Taizhou
2026-04-15
Not yet open
Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies
NCT07485504Relapsed or Refractory Hematologic Malignancies
Tcelltech Inc.
Phase 1
15
Tianjin
2026-04-15
Recruiting
Tianjin Medical University Cancer Institute and Hospital
Phase 2
40
Tianjin
2026-04-14
Recruiting
A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma
NCT07493135Relapsed/Refractory Multiple Myeloma
Suzhou Immunofoco Biotechnology Co., Ltd
Early Phase 1
30
Beijing, Chongqing, Shanghai, Zhengzhou
2026-04-14
Recruiting
Renmin Hospital of Wuhan University
Phase 2
33
Wuhan
2026-04-14
Recruiting
Eli Lilly and Company
Phase 2
65
Beijing, Shanghai, Tianjin
2026-04-14
Recruiting
Anrikefon-based Patient-controlled Intravenous Analgesia Following Laparoscopic Surgery
NCT07525986Laparoscopic Surgery, Visceral Pain, Postoperative, Anrikefon, Patient-controlled Intravenous Analgesia
DrugsAnrikefon·Morphine
Peking University First Hospital
Phase 4
140
Beijing, Shenzhen, Changsha
2026-04-14
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
36
Fuzhou, Nanning
2026-04-14
Recruiting
Affiliated Hospital to Academy of Military Medical Sciences
Early Phase 1
20
Beijing
2026-04-14
Recruiting
Peking University Cancer Hospital & Institute
Observational
20
Beijing
2026-04-14
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
800
Chizhou, Hefei, Chongqing, Zhangzhou, Lanzhou, Foshan, Shenzhen, Guiyang
2026-04-14
Recruiting
Nanfang Hospital, Southern Medical University
Not applicable
174
Guangzhou
2026-04-14
Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
NCT07533019Vitiligo, Non-Segmental Vitiligo (NSV)
DrugLY4005130
Eli Lilly and Company
Phase 2
66
Beijing, Hangzhou, Shanghai, Shenzhen
2026-04-14
Active, closed
Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Phase 3
60
Tianjin, Fuyang, Fuzhou, Ganzhou, Guangzhou, Hefei, Huai'an, Jinan
2026-04-14
Recruiting
Xuanwu Hospital, Beijing
Phase 3
246
Beijing
2026-04-14
Active, closed
Beijing QL Biopharmaceutical Co.,Ltd
Phase 1
40
Xiamen, Jinan, Chengdu
2026-04-13
Recruiting
Beijing Tsinghua Chang Gung Hospital
Observational
40
Beijing
2026-04-13
Rows per page Showing 3001–3500 of 19187
Previous 5 6 7 8 9 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 7 November 2026. https://priyalifescience.com/clinical-trials-china?page=7

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 07 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in China?

11,790 of the 19,187 studies in this register are recruiting new participants as of the 07 Nov 2026, 03:17 UTC sync. A further 3,998 have not yet opened recruitment, 2,715 are active but closed to new participants, and 684 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (423) Advanced Solid Tumors (187) Colorectal Cancer (179) Gastric Cancer (175) Hepatocellular Carcinoma (154) Advanced Solid Tumor (153) Non-Small Cell Lung Cancer (145) Solid Tumor (142) Acute Ischemic Stroke (140) Lung Cancer (135) Non-small Cell Lung Cancer (132) Pancreatic Cancer (131) Multiple Myeloma (128) Coronary Artery Disease (122) Prostate Cancer (110)
→

Browse trials by site location

Beijing (5576) Shanghai (3879) Guangzhou (3345) Hangzhou (1819) Wuhan (1343) Chengdu (1307) Nanjing (1211) Changsha (1154) Chongqing (1078) Fuzhou (1040) Tianjin (934) Zhengzhou (931) Hefei (896) Jinan (783) Changchun (639)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.